论文信息 - Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort. - 字舞流文

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort.

S. Michiels | C. Lebbé | B. Dréno | S. Dalle | M. Beylot-Barry | F. Rotolo | P. Stoebner | B. Guillot | L. Mortier | P. Saiag | S. Dalac | F. Aubin | C. Dutriaux | E. Maubec | T. Lesimple | J. Lacour | I. Borget | M. Leccia | C. Allayous | J. Arnault | F. Brunet-Possenti | F. Granel-Brocard | D. Legoupil | J. Grob | M. Kandel | A. Dupuy | A. Ballon | A. Dupuy | P. Stoebner | F. Granel‐Brocard | M. Beylot‐Barry | F. Brunet‐Possenti | Isabelle Borget | L. Mortier | M. Beylot-Barry | J.-P. Lacour | S. Dalle | Bernard Guillot | François Aubin | Stefan Michiels